MSAC consultations

The Medical Services Advisory Committee (MSAC) meets 3 times a year to assess applications of new medical services. For most items being considered there are 2 consultation periods: prior to the PICO Advisory Sub-Committee (PASC) meeting, and prior to the MSAC meeting.

Learn more about the MSAC and the Medicare Benefits Schedule (MBS).

Open MSAC consultations

Listed below and via the ‘show more’ button are open consultations for items being considered by the MSAC.

MSAC Consultation Survey - Application 1790

MSAC application 1790 POLE genotyping for the molecular classification of endometrial cancer. Consultation is open on applications for consideration by the Medical Services Advisory...

More

MSAC Consultation Survey - Application 1796

MSAC application 1796 ADAMTS13 testing for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Consultation is open on applications for consideration by the Medical Services...

More

MSAC Consultation Survey - Application 1804

MSAC application 1804 - Genetic testing to detect RET variants in patients with medullary thyroid cancer to determine eligibility for PBS subsidised selpercatinib treatment. ...

More

MSAC Consultation Survey - Application 1805

MSAC application 1805 - Concizumab for routine prophylaxis to prevent bleeding in patients with haemophilia B. Consultation is open on applications for consideration by the Medical...

More

MSAC Consultation Survey - Application 1806

MSAC application 1806 - Marstacimab for routine prophylaxis to prevent bleeding in patients with haemophilia. Consultation is open on applications for consideration by the Medical...

More

MSAC Consultation Survey - Application 1657.1

MSAC application 1657.1 Rhenium-188 brachytherapy for non-melanoma skin cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC)...

More

MSAC Consultation Survey - Application 1811

MSAC application 1811 Testing for MET overexpression and amplification in patients with locally advanced or metastatic non-small cell lung cancer to determine eligibility for treatment with PBS...

More

MSAC Consultation Survey - Application 1809

MSAC application 1809 Genomic testing in cancer of unknown primary (CUP) and diagnostically challenging cancers. Consultation is open on applications for consideration by the Medical...

More

MSAC Consultation Survey - Application 1812

MSAC application 1812 Transcatheter Edge-To-Edge Repair (TEER) for the treatment of severe tricuspid regurgitation (TR) using the TriClip device. Consultation is open on applications...

More
Show more

MSAC Updates

Subscribe to MSAC email bulletins on the MSAC meeting agendas and consultations, and important updates.

Sign up